目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Precision Medicine Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Precision Medicine Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape

Chapter 4. Precision Medicine: Application Estimates & Trend Analysis
4.1. Precision Medicine Market: Key Takeaways
4.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Diagnostics
4.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Genetic tests
4.3.2.1. Genetic tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Direct to consumer tests
4.3.3.1. Direct to consumer tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Esoteric tests
4.3.4.1. Esoteric tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. Others
4.3.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Therapeutics
4.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Pharmaceuticals
4.4.2.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.2. Oncology
4.4.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.3. Respiratory diseases
4.4.2.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.4. Skin diseases
4.4.2.4.1. Skin diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.5. CNS disorders
4.4.2.5.1. CNS disorders market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.6. Immunology
4.4.2.6.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.7. Genetic diseases
4.4.2.7.1. Genetic diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.8. Others
4.4.2.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Medical Devices
4.4.3.1. Medical Devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Precision Medicine: End Use Estimates & Trend Analysis
5.1. Precision Medicine Market: Key Takeaways
5.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Home Care
5.3.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Clinical Laboratories
5.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Precision Medicine Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. F. Hoffmann-La Roche Ltd.-Foundation Medicine
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Siemens Healthineers
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Janssen Pharmaceuticals
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Illumina
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Quest Diagnostics Incorporated.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. 23andMe, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. NeoDiagnostix, Inc.,
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. IBM Watson
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Myriad Genetics Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Medtronic
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. GE Healthcare
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Abbott Laboratories
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Dako A/S
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Biogen
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. Precision Biologics Incorporated
7.2.15.1. Company overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
7.2.16. Qiagen Incorporated
7.2.16.1. Company overview
7.2.16.2. Financial performance
7.2.16.3. Product benchmarking
7.2.16.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviations
Table 2 North America precision medicine market, by application, 2018 - 2030 (USD Million)
Table 3 North America precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 4 North America precision medicine market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. precision medicine market, by application, 2018 - 2030 (USD Million)
Table 6 U.S. precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 7 Canada precision medicine market, by application, 2018 - 2030 (USD Million)
Table 8 Canada precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 9 Europe precision medicine market, by application, 2018 - 2030 (USD Million)
Table 10 Europe precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 11 Europe precision medicine market, by region, 2018 - 2030 (USD Million)
Table 12 Germany precision medicine market, by application, 2018 - 2030 (USD Million)
Table 13 Germany precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 14 UK precision medicine market, by application, 2018 - 2030 (USD Million)
Table 15 UK precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 16 France precision medicine market, by application, 2018 - 2030 (USD Million)
Table 17 France precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 18 Italy precision medicine market, by application, 2018 - 2030 (USD Million)
Table 19 Italy precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 20 Spain precision medicine market, by application, 2018 - 2030 (USD Million)
Table 21 Spain precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 22 Sweden precision medicine market, by application, 2018 - 2030 (USD Million)
Table 23 Sweden precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 24 Norway precision medicine market, by application, 2018 - 2030 (USD Million)
Table 25 Norway precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark precision medicine market, by application, 2018 - 2030 (USD Million)
Table 27 Denmark precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 28 Asia Pacific precision medicine market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific precision medicine market, by region, 2018 - 2030 (USD Million)
Table 31 China precision medicine market, by application, 2018 - 2030 (USD Million)
Table 32 China precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 33 Japan precision medicine market, by application, 2018 - 2030 (USD Million)
Table 34 Japan precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 35 India precision medicine market, by application, 2018 - 2030 (USD Million)
Table 36 India precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 37 Australia precision medicine market, by application, 2018 - 2030 (USD Million)
Table 38 Australia precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 39 Thailand precision medicine market, by application, 2018 - 2030 (USD Million)
Table 40 Thailand precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 41 South Korea precision medicine market, by application, 2018 - 2030 (USD Million)
Table 42 South Korea precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 43 Latin America precision medicine market, by application, 2018 - 2030 (USD Million)
Table 44 Latin America precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 45 Latin America precision medicine market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil precision medicine market, by application, 2018 - 2030 (USD Million)
Table 47 Brazil precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 48 Mexico precision medicine market, by application, 2018 - 2030 (USD Million)
Table 49 Mexico precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 50 Argentina precision medicine market, by application, 2018 - 2030 (USD Million)
Table 51 Argentina precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa precision medicine market, by application, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa precision medicine market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa precision medicine market, by application, 2018 - 2030 (USD Million)
Table 56 South Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia precision medicine market, by application, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 59 UAE precision medicine market, by application, 2018 - 2030 (USD Million)
Table 60 UAE precision medicine market, by end-use, 2018 - 2030 (USD Million)
Table 61 Kuwait precision medicine market, by application, 2018 - 2030 (USD Million)
Table 62 Kuwait precision medicine market, by end-use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Precision medicine: Market outlook
Fig. 9 Precision medicine: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Precision medicine market driver impact
Fig. 15 Precision medicine market restraint impact
Fig. 16 Precision medicine market strategic initiatives analysis
Fig. 17 Precision medicine market: Application movement analysis
Fig. 18 Precision medicine market: Application outlook and key takeaways
Fig. 19 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Genetic tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Direct to consumer tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Esoteric tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Skin diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 CNS disorders market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Genetic diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Precision medicine market: End-use movement analysis
Fig. 36 Precision medicine market: End-use outlook and key takeaways
Fig. 37 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Global precision medicine market: Regional movement analysis
Fig. 42 Global precision medicine market: Regional outlook and key takeaways
Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)